Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7

Non-keratinizing nasopharyngeal carcinoma, the major subtype of nasopharyngeal carcinoma, is characterized by low differentiation and a close relation to Epstein-Barr virus infection, which indicates a link between Epstein-Barr virus oncogenesis and loss of differentiation, and raises our interest in investigating the involvement of Epstein-Barr virus in nasopharyngeal carcinoma dedifferentiation. Our previous study showed abundant expression of an Epstein-Barr virus-encoded microRNA, BART10-3p, in nasopharyngeal carcinoma tissues, but the association between BART10-3p and nasopharyngeal carcinoma differentiation remains unknown. Here, we examined the expression and prognostic value of BART10-3p, and undertook bioinformatics analysis and functional assays to investigate the influence of BART10-3p on nasopharyngeal carcinoma differentiation and proliferation and the underpinning mechanism. Microarray analysis identified BART10-3p as the most significantly upregulated Epstein-Barr virus-encoded microRNA in nasopharyngeal carcinoma tissues and the upregulation was confirmed in two public datasets. The expression of BART10-3p was an independent unfavorable prognosticator in nasopharyngeal carcinoma and its integration with the clinical stage showed improved prognosis predictive performance. Bioinformatics analysis suggested a potential role of BART10-3p in tumor differentiation and progression. Functional assays demonstrated that BART10-3p could promote nasopharyngeal carcinoma cell dedifferentiation, epithelial-mesenchymal transition, and proliferation in vitro, and tumorigenicity in vivo. Mechanistically, BART10-3p directly targeted the 3′UTR of ALK7 and suppressed its expression. Reconstitution of ALK7 rescued BART10-3p-induced malignant phenotypes. Overall, our study demonstrates that BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7, suggesting a promising therapeutic opportunity to reverse the malignant phenotypes of nasopharyngeal carcinoma.

[1]  C. Tsang,et al.  EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7 , 2019, Front. Genet..

[2]  Zhen Liu,et al.  Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway , 2019, EBioMedicine.

[3]  D. Hanahan,et al.  ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis. , 2019, Developmental cell.

[4]  Suk-Kyeong Lee,et al.  EBV miR-BART10-3p Promotes Cell Proliferation and Migration by Targeting DKK1 , 2019, International journal of biological sciences.

[5]  P. Farrell.  Epstein-Barr Virus and Cancer. , 2019, Annual review of pathology.

[6]  Bin Zhang,et al.  EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways , 2018, Journal of experimental & clinical cancer research : CR.

[7]  C. Eberhart,et al.  ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma , 2018, Oncogene.

[8]  Zuzana Vojtěchová,et al.  The Role of miRNAs in Virus-Mediated Oncogenesis , 2018, International journal of molecular sciences.

[9]  S. Sell,et al.  Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy. , 2016, Current drug targets.

[10]  R. Li,et al.  EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop , 2016, Oncogene.

[11]  R. Feederle,et al.  A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog , 2016, PLoS pathogens.

[12]  Z. Zeng,et al.  EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC , 2015, Oncotarget.

[13]  S. Pauklin,et al.  Activin/Nodal signalling in stem cells , 2015, Development.

[14]  Yasuhiro Yamada,et al.  Concise Review: Dedifferentiation Meets Cancer Development: Proof of Concept for Epigenetic Cancer , 2014, Stem cells translational medicine.

[15]  D. Thorley-Lawson,et al.  EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells , 2014, Proceedings of the National Academy of Sciences.

[16]  Feimeng Zheng,et al.  IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation , 2014, Nature Communications.

[17]  W. Xie,et al.  Differentiation therapy for solid tumors , 2014, Journal of digestive diseases.

[18]  D. Jin,et al.  The pathological roles of BART miRNAs in nasopharyngeal carcinoma , 2012, The Journal of pathology.

[19]  D. Kwong,et al.  Profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs , 2012, Cancer.

[20]  G. Fu,et al.  MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance , 2011, Journal of Cell Science.

[21]  N. Raab-Traub,et al.  Epstein Barr-Virus Latent Membrane Protein-2A-Induced ΔNp63α Expression is Associated with Impaired Epithelial Cell Differentiation , 2010, Oncogene.

[22]  Philippe Froguel,et al.  ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease , 2009, Biochemical and biophysical research communications.

[23]  C. Ibáñez,et al.  Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity , 2008, Proceedings of the National Academy of Sciences.

[24]  K. Tsuchida,et al.  Activin isoforms signal through type I receptor serine/threonine kinase ALK7 , 2004, Molecular and Cellular Endocrinology.

[25]  Anton J. Enright,et al.  Identification of Virus-Encoded MicroRNAs , 2004, Science.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  A. Brivanlou,et al.  The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. , 2001, Genes & development.

[28]  S. P. Reddy,et al.  Prognostic significance of keratinization in nasopharyngeal carcinoma. , 1995, American journal of otolaryngology.

[29]  K. Yao,et al.  Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Sarov,et al.  Significance of Specific Epstein‐Barr Virus IgA and Elevated IgG Antibodies to Viral Capsid Antigens in Nasopharyngeal Carcinoma Patients , 1986, Journal of medical virology.